Intracoronary Near-Infrared Spectroscopy (NIRS) Imaging for Detection of Lipid Content of Coronary Plaques: Current Experience and Future PerspectivesHappy heart syndrome: role of positive emotional stress in takotsubo syndromeFeasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenariosBasic laboratory parameters as predictors of in-hospital death in patients with acute decompensated heart failure: data from a large single-centre cohort.Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes.Differences in the Clinical Profile and Outcomes of Typical and Atypical Takotsubo Syndrome: Data From the International Takotsubo Registry.Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity catheter system and the EnligHTN multi-electrode renal denervation catheterPatients' perception of pharmaceutical services available in a community pharmacy among patients living in a rural area of the United KingdomA signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarctionOff-label indications for bioresorbable scaffolds: "Beethoven can, but you cannot".The first reported aspiration thrombectomy with a guide extension mother-and-child catheter in ST elevation myocardial infarction due to bacterial vegetation coronary artery embolismThe pharmaceutical care in asthma - Polish and global perspective.The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From OptPharmaceutical services as a tool to improve outcomes in patients with cardiovascular diseases.The role of the pharmacist in the care of patients with cardiovascular diseases.Cardiac CT and echocardiographic evaluation of peri-device flow after percutaneous left atrial appendage closure using the AMPLATZER cardiac plug device.Bas-relief in three dimensional optical coherence tomography: a novel sign after subintimal scaffolding in a chronic total occlusion.Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome.Drug-eluting stents compared to bare-metal stents improve short-term survival in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a nationwide prospective analysis of the AMIS Plus registry.Multivessel versus culprit vessel percutaneous coronary intervention in ST-elevation myocardial infarction: is more worse?Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: a nationwide study cohort from the AMIS Plus registry.Patient-prosthesis mismatch after mitral valve-in-valve procedure - at the cost of life or serious consequence?Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation.Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy.Optical Coherence Tomography Imaging: Novel Insights into the Vascular Response After Coronary Stent ImplantationPaclitaxel-Coated Balloons: Investigation of Drug Transfer in Healthy and Atherosclerotic Arteries - First Experimental Results in Rabbits at Low Inflation Pressure.Drug-eluting stents vs. bare metal stents in patients with cardiogenic shock: a comparison by propensity score analysis.Successful versus unsuccessful antegrade recanalization of single chronic coronary occlusion: eight-year experience and outcomes by a propensity score ascertainment.Optical coherence tomography to reveal vascular lesions after catheter-based renal nerve ablation with a novel multi-electrode EnligHTN™ system.Geometrically correct three-dimensional optical coherence tomography: first self-expanding bifurcation stent evaluation.Impact of inflammation on adverse cardiovascular events in patients with acute coronary syndromes.Gender disparities in acute coronary syndrome: a closing gap in the short-term outcome.Acute thrombosis of bioabsorbable scaffold in a patient with acute coronary syndrome.Levosimendan: New hope therapy for takotsubo syndrome.Medication adherence in patients after percutaneous coronary intervention due to acute myocardial infarction: From research to clinical implications.Takotsubo cardiomyopathy induced by a suicide attempt.Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland.Awareness of the implementation of the Falsified Medicines Directive among pharmaceutical companies' professionals in the European Economic Area.CMR to distinguish Takotsubo cardiomyopathy from myocardial infarction in acute course of ischemic stroke in a male patient.Brain resting state functional magnetic resonance imaging in patients with takotsubo cardiomyopathy an inseparable pair of brain and heart.
P50
Q26992156-B01FA536-E99B-4356-8EB0-0C5DBA4A4590Q28005543-C880DC27-C99B-42EA-973D-96B37427A98BQ30619558-366A750D-E094-4EFD-B3AF-9016B52BA209Q31135430-F3798F71-D318-46AB-9C6D-3F8FD0F0CA83Q35558887-2DF9B6A4-6C3E-40D7-9974-4E66B53C6FA8Q36082800-19D87A9F-DB35-43F1-9740-F7A7CAC07537Q37029402-14E2813A-F946-4E92-A68D-A13372D4D671Q37334526-DA0A9DA8-CFAA-4201-8A92-7337D0C7D98AQ37334526-E4D06F6F-C083-43AA-9769-AB99AD453B65Q37700310-7CA21987-3847-4782-B6A3-F299562CA396Q38768773-BE03E1DA-7892-436B-8278-DD0AF7DAE0D5Q38768991-111B66BE-3B2A-4361-B75D-185F28D97A3AQ38840045-D578150A-898B-4930-ADD4-97DC9B2B554CQ38916942-4B95248F-2106-46BD-B615-0B253CB2D7B2Q38920348-41778B30-194A-469A-9A64-65D83EAA7448Q38974752-672FD6FA-A336-4BC2-92A8-A9BE3B6B85AFQ39131805-2B7B220F-320D-4825-98A0-8B3D92CFFD92Q39158069-2E7CF0EC-AE66-4849-9AC1-AD823E5A3D10Q39632788-C527CEE0-28DF-49E0-9C02-F7A567BF3BE8Q40154511-57ABB1B1-75AF-42C5-BEE2-74AB9FDDA01EQ40161223-B6626960-2E77-4531-9935-7C1429E9D7BAQ40166544-7FABAB06-E1E4-413C-AAF0-19819C1E5BD6Q41254358-2C016E3C-D222-4D10-B947-D49E772205D3Q41307231-9B91B3FF-999B-47C7-854E-98775FDD07C8Q41430430-50F24823-A90F-4C52-8856-60CEC2EC27F2Q42154709-7CE00028-30B6-416E-A8B5-17FA6D8D3E8FQ42548668-7765591A-B947-4C62-8EF6-6FFA2174EB0DQ42669279-54FAF3CA-1C62-4055-B7C9-F8F7E9C8CBA6Q43607700-F996F5E6-8320-4EA6-A1E3-A5D018590954Q43919062-24F53DB6-703E-481A-9865-0C0EC77BB9F8Q44136872-1795139E-E892-4FA6-84A6-32680A2FFD3EQ44356279-54066C48-8C9A-4E1B-8D14-06B6BDAD1EF4Q46618331-A2685735-B699-4FB7-B2E8-B2AD7270E522Q46850956-8C564830-B7F3-48A8-A758-D2EE98C6A2B9Q47593886-CEC3931C-A61A-4C5E-9698-A1F363F55045Q48048093-765D8FFE-7688-4863-AB00-AC6687FC1AEFQ48109679-EDAF4089-29A0-40D4-830A-D527F1FCC25CQ48213904-CC9EFE73-3E4D-4D41-8F17-8FF665133103Q48275857-CF643F81-F1BA-462C-BC00-57350973E3CDQ48275857-D69940D8-72B4-481D-AA50-4209057F2B84
P50
description
Polish cardiologist
@en
Pools onderzoeker
@nl
polski lekarz, kardiolog
@pl
հետազոտող
@hy
name
Milosz Jaguszewski
@ast
Milosz Jaguszewski
@en
Milosz Jaguszewski
@es
Milosz Jaguszewski
@nl
Miłosz Jaguszewski
@ca
Miłosz Jaguszewski
@cs
Miłosz Jaguszewski
@gl
Miłosz Jaguszewski
@hr
Miłosz Jaguszewski
@hsb
Miłosz Jaguszewski
@it
type
label
Milosz Jaguszewski
@ast
Milosz Jaguszewski
@en
Milosz Jaguszewski
@es
Milosz Jaguszewski
@nl
Miłosz Jaguszewski
@ca
Miłosz Jaguszewski
@cs
Miłosz Jaguszewski
@gl
Miłosz Jaguszewski
@hr
Miłosz Jaguszewski
@hsb
Miłosz Jaguszewski
@it
altLabel
Miłosz J. Jaguszewski
@pl
Miłosz Jarosław Jaguszewski
@pl
prefLabel
Milosz Jaguszewski
@ast
Milosz Jaguszewski
@en
Milosz Jaguszewski
@es
Milosz Jaguszewski
@nl
Miłosz Jaguszewski
@ca
Miłosz Jaguszewski
@cs
Miłosz Jaguszewski
@gl
Miłosz Jaguszewski
@hr
Miłosz Jaguszewski
@hsb
Miłosz Jaguszewski
@it
P214
P106
P1153
56175177200
P1412
P1559
Miłosz Jaguszewski
@pl
P18
P21
P214
P27
P31
P3124
P496
0000-0002-2555-593X
0000-0003-2032-7484
P5008
P734
P7859
viaf-317156406